119 related articles for article (PubMed ID: 12652560)
1. Dynamic Cox modelling based on fractional polynomials: time-variations in gastric cancer prognosis.
Berger U; Schäfer J; Ulm K
Stat Med; 2003 Apr; 22(7):1163-80. PubMed ID: 12652560
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer.
Royston P; Parmar MK; Sylvester R
Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080
[TBL] [Abstract][Full Text] [Related]
3. Reduced-rank hazard regression for modelling non-proportional hazards.
Perperoglou A; le Cessie S; van Houwelingen HC
Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
[TBL] [Abstract][Full Text] [Related]
4. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
5. Parsimonious analysis of time-dependent effects in the Cox model.
Lehr S; Schemper M
Stat Med; 2007 Jun; 26(13):2686-98. PubMed ID: 17094129
[TBL] [Abstract][Full Text] [Related]
6. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
7. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
Wong MC; Lam KF; Lo EC
Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
[TBL] [Abstract][Full Text] [Related]
8. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
[TBL] [Abstract][Full Text] [Related]
9. Artificial neural network for the joint modelling of discrete cause-specific hazards.
Biganzoli EM; Boracchi P; Ambrogi F; Marubini E
Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963
[TBL] [Abstract][Full Text] [Related]
10. Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy.
Binquet C; Abrahamowicz M; Mahboubi A; Jooste V; Faivre J; Bonithon-Kopp C; Quantin C
Stat Med; 2008 Dec; 27(30):6470-88. PubMed ID: 18837067
[TBL] [Abstract][Full Text] [Related]
11. Comparing proportional hazards and accelerated failure time models for survival analysis.
Orbe J; Ferreira E; Núñez-Antón V
Stat Med; 2002 Nov; 21(22):3493-510. PubMed ID: 12407686
[TBL] [Abstract][Full Text] [Related]
12. A relative survival regression model using B-spline functions to model non-proportional hazards.
Giorgi R; Abrahamowicz M; Quantin C; Bolard P; Esteve J; Gouvernet J; Faivre J
Stat Med; 2003 Sep; 22(17):2767-84. PubMed ID: 12939785
[TBL] [Abstract][Full Text] [Related]
13. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
14. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
Royston P; Parmar MK
Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
[TBL] [Abstract][Full Text] [Related]
15. The estimation of average hazard ratios by weighted Cox regression.
Schemper M; Wakounig S; Heinze G
Stat Med; 2009 Aug; 28(19):2473-89. PubMed ID: 19472308
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival with non-proportional hazards: results from the Dutch Gastric Cancer Trial.
Putter H; Sasako M; Hartgrink HH; van de Velde CJ; van Houwelingen JC
Stat Med; 2005 Sep; 24(18):2807-21. PubMed ID: 16134134
[TBL] [Abstract][Full Text] [Related]
17. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
[TBL] [Abstract][Full Text] [Related]
18. Generating survival times to simulate Cox proportional hazards models.
Bender R; Augustin T; Blettner M
Stat Med; 2005 Jun; 24(11):1713-23. PubMed ID: 15724232
[TBL] [Abstract][Full Text] [Related]
19. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT
Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
